Adherence Evaluation in COPD
Evaluation of Perception and Knowledge of Adherence to COPD Inhalation Therapy at Patient, GP and Pulmonologist Level
1 other identifier
observational
260
1 country
1
Brief Summary
The rationale of this study is to have a better understanding of the perception of the pulmonologists, general practitioners and patients of adherence (causes, main consequences, supportive tools,..) and the use of TAI-questionnaire (appreciation, usability,…) by interviewing pulmonologists \& general practitioners and a survey with patients. Based on the outcome, projects and tools can be developed to help health care professionals to motivate patients to improve adherence and to help patients to increase their adherence to inhalation therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedFirst Submitted
Initial submission to the registry
January 15, 2020
CompletedFirst Posted
Study publicly available on registry
January 29, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2020
CompletedMarch 26, 2020
March 1, 2020
2 months
January 15, 2020
March 25, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Knowledge and perception of adherence
Gathering knowledge based on semi-structured interview (definition, causes, consequences of bad adherence,...)
Baseline
Secondary Outcomes (1)
Test of the adherence to inhalers-questionnaire (TAI)
Baseline
Study Arms (3)
Pulmonologists
Interviews with pulmonologists
General practitioners
Interviews with general practitioners
Patients
Survey with COPD patients
Interventions
No intervention -\> survey at 1 timepoint
Eligibility Criteria
Pulmonologists, general practicioners and COPD patients
You may qualify if:
- Pulmonologists or general practitioners or COPD patient (suffering from COPD treated with inhalation therapy)
You may not qualify if:
- Not applicable
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Chiesi SA/NVlead
Study Sites (1)
Medistrat
Lasne, Belgium
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Sofie Geelissen, PhD
Chiesi Belgium
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 15, 2020
First Posted
January 29, 2020
Study Start
January 1, 2020
Primary Completion
March 15, 2020
Study Completion
June 30, 2020
Last Updated
March 26, 2020
Record last verified: 2020-03